Yen‐Hao Chen

2.1k total citations
84 papers, 1.0k citations indexed

About

Yen‐Hao Chen is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Yen‐Hao Chen has authored 84 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Surgery, 24 papers in Pulmonary and Respiratory Medicine and 23 papers in Oncology. Recurrent topics in Yen‐Hao Chen's work include Esophageal Cancer Research and Treatment (23 papers), Esophageal and GI Pathology (13 papers) and Gastric Cancer Management and Outcomes (12 papers). Yen‐Hao Chen is often cited by papers focused on Esophageal Cancer Research and Treatment (23 papers), Esophageal and GI Pathology (13 papers) and Gastric Cancer Management and Outcomes (12 papers). Yen‐Hao Chen collaborates with scholars based in Taiwan, United States and China. Yen‐Hao Chen's co-authors include Shau-Hsuan Li, Hung‐I Lu, Hung-yi Lee, Yu‐Ming Wang, Tsung-Han Wu, Po-Han Chi, Shang-Wen Li, Ming-Yen Tsai, Kun‐Ming Rau and Yu‐Chuen Huang and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Yen‐Hao Chen

75 papers receiving 972 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yen‐Hao Chen Taiwan 17 211 186 184 173 138 84 1.0k
Jin Han United States 22 599 2.8× 113 0.6× 322 1.8× 73 0.4× 54 0.4× 78 2.1k
Xiaoli Cui China 20 541 2.6× 117 0.6× 309 1.7× 251 1.5× 97 0.7× 89 1.6k
Khoa Tran Vietnam 7 189 0.9× 44 0.2× 123 0.7× 147 0.8× 181 1.3× 20 721
Fengquan Dong China 14 182 0.9× 84 0.5× 40 0.2× 104 0.6× 65 0.5× 25 628
Sheng‐Tang Wu Taiwan 20 398 1.9× 242 1.3× 142 0.8× 219 1.3× 295 2.1× 118 1.6k
Yueh‐Chun Lee Taiwan 19 324 1.5× 100 0.5× 188 1.0× 164 0.9× 52 0.4× 72 961
Matthias Großmann Germany 16 539 2.6× 88 0.5× 203 1.1× 376 2.2× 23 0.2× 39 1.5k
Rui Hou China 22 357 1.7× 73 0.4× 109 0.6× 116 0.7× 174 1.3× 115 1.2k

Countries citing papers authored by Yen‐Hao Chen

Since Specialization
Citations

This map shows the geographic impact of Yen‐Hao Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yen‐Hao Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yen‐Hao Chen more than expected).

Fields of papers citing papers by Yen‐Hao Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yen‐Hao Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yen‐Hao Chen. The network helps show where Yen‐Hao Chen may publish in the future.

Co-authorship network of co-authors of Yen‐Hao Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Yen‐Hao Chen. A scholar is included among the top collaborators of Yen‐Hao Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yen‐Hao Chen. Yen‐Hao Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Yen‐Hao, et al.. (2024). Tepotinib in Cholangiocarcinoma with MET Amplification: A Case Report. OncoTargets and Therapy. Volume 17. 857–861.
2.
Chen, Yen‐Hao, et al.. (2024). Efficacy and safety of durvalumab rechallenge in advanced hepatocellular carcinoma patients refractory to prior anti-PD-1 therapy. Hepatology International. 18(6). 1804–1814. 5 indexed citations
3.
Chen, Yen‐Hao, Wan‐Ting Huang, Wen‐Chin Lee, et al.. (2024). Urine Phthalate Metabolites are Elevated in Patients with Esophageal Squamous Cell Carcinoma and Associated with Advanced Cancer Stage and Poor Survival. Cancer Management and Research. Volume 16. 989–1001. 1 indexed citations
4.
Lu, Hung‐I, Yu‐Ming Wang, Yen‐Hao Chen, et al.. (2024). Preoperative neutrophil–to–lymphocyte ratio after chemoradiotherapy for esophageal squamous cell carcinoma associates with postoperative pulmonary complications following radical esophagectomy. SHILAP Revista de lepidopterología. 13(1). 65–65. 1 indexed citations
5.
Hsiao, Ya‐Wen, Jing‐Houng Wang, Yen‐Hao Chen, et al.. (2023). Well‐controlled viremia reduces the progression of hepatocellular carcinoma in chronic viral hepatitis patients treated with lenvatinib. The Kaohsiung Journal of Medical Sciences. 39(12). 1233–1242. 1 indexed citations
6.
Wang, Chih‐Chi, Wen‐Lang Fan, Tingting Liu, et al.. (2023). Impact of Genomic Alterations on the Clinical Outcome of Patients With Hepatitis B-related Hepatocellular Carcinoma Receiving Curative Surgery: A Retrospective Cohort Study. Anticancer Research. 43(10). 4709–4722. 1 indexed citations
7.
Lu, Hung‐I, Yen‐Hao Chen, Fu‐Min Fang, et al.. (2022). The Radiation Dose to the Left Supraclavicular Fossa is Critical for Anastomotic Leak Following Esophagectomy – A Dosimetric Outcome Analysis. Cancer Management and Research. Volume 14. 1603–1613.
8.
9.
Jiang, He‐Jiun, Yen‐Hsiang Chang, Yen‐Hao Chen, et al.. (2021). Low Dose of Lenvatinib Treatment for Patients of Radioiodine-Refractory Differentiated Thyroid Carcinoma – A Real-World Experience. Cancer Management and Research. Volume 13. 7139–7148. 12 indexed citations
10.
Liu, Yuyin, Yueh‐Wei Liu, Yen‐Yang Chen, et al.. (2021). The efficacy and toxicity of adjuvant S-1 schedule with 2-week administration followed by 1-week rest in gastric cancer patients. Journal of Gastrointestinal Oncology. 12(2). 297–306. 1 indexed citations
11.
Chen, Yen‐Hao, et al.. (2020). Effectiveness of Combined Treatment with Traditional Chinese Medicine and Western Medicine on the Prognosis of Patients with Breast Cancer. The Journal of Alternative and Complementary Medicine. 26(9). 835–842. 29 indexed citations
12.
Chen, Yen‐Yang, et al.. (2020). Efficacy and safety of uracil-tegafur in patients with recurrent or metastatic thymic carcinoma. Journal of Cancer Research and Practice. 7(3). 111–111. 1 indexed citations
13.
Chen, Yen‐Hao, et al.. (2020). VQVC+: One-Shot Voice Conversion by Vector Quantization and U-Net Architecture. 4691–4695. 51 indexed citations
14.
Chen, Li-Chun, Shau-Hsuan Li, Yen‐Hao Chen, et al.. (2019). Platelet-to-lymphocyte ratio is an independent prognosticator in patients with esophageal squamous cell carcinoma receiving esophagectomy. Journal of Thoracic Disease. 11(11). 4583–4590. 12 indexed citations
15.
Chen, Yen‐Hao, Hung‐I Lu, Chih‐Yen Chien, et al.. (2017). Treatment Outcomes of Patients with Locally Advanced Synchronous Esophageal and Head/Neck Squamous Cell Carcinoma Receiving Curative Concurrent Chemoradiotherapy. Scientific Reports. 7(1). 41785–41785. 24 indexed citations
16.
Lu, Shin-Yu, Shu‐Hua Huang, & Yen‐Hao Chen. (2017). Numb chin with mandibular pain or masticatory weakness as indicator for systemic malignancy – A case series study. Journal of the Formosan Medical Association. 116(11). 897–906. 9 indexed citations
17.
Ma, Ming‐Chun, Yen‐Yang Chen, Shau-Hsuan Li, et al.. (2014). Intra-Arterial Chemotherapy with Doxorubicin and Cisplatin Is Effective for Advanced Hepatocellular Cell Carcinoma. The Scientific World JOURNAL. 2014. 1–8. 14 indexed citations
18.
Chen, Yen‐Hao & Cheng-Hua Huang. (2012). Reversible Posterior Leukoencephalopathy Syndrome Induced by Vinorelbine. Clinical Breast Cancer. 12(3). 222–225. 10 indexed citations
19.
Wang, Hwei‐Ming, et al.. (2011). Colorectal Cancer in Younger than 30 Years Old Group is not Associated with Poor Prognosis. 22(3). 93–98. 4 indexed citations
20.
Ueda, Eric, Uğur Özerdem, Yen‐Hao Chen, et al.. (2006). A molecular mimic demonstrates that phosphorylated human prolactin is a potent anti-angiogenic hormone. Endocrine Related Cancer. 13(1). 95–111. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jin Han Breakdown of academic impact, for papers by Xiaoli Cui Breakdown of academic impact, for papers by Khoa Tran Breakdown of academic impact, for papers by Fengquan Dong Breakdown of academic impact, for papers by Sheng‐Tang Wu Breakdown of academic impact, for papers by Yueh‐Chun Lee Breakdown of academic impact, for papers by Matthias Großmann Breakdown of academic impact, for papers by Rui Hou
Rankless by CCL
2026